Suspension of trading

News Venus Concept Inc.

Stocks

VERO

US92332W3034

Advanced Medical Equipment & Technology

Delayed OTC Markets Other stock markets 12:44:37 2026-04-06 pm EDT			5-day change	1st Jan Change
0.3105 ^USD	+2.56%		-.--%	-79.02%

May. 13	Venus Concept Inc. Announces Senior Management Changes	CI
Apr. 08	Venus Concept Inc. announced that it has received $1.5 million in funding	CI

All News

Mentions Relevance

May. 14	Venus Concept Announces Senior Management Changes	AQ
May. 13	Venus Concept Inc. Announces Senior Management Changes	CI
Apr. 08	Venus Concept Inc. announced that it has received $1.5 million in funding	CI
Apr. 01	Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger	AQ
Mar. 25	Venus Concept Inc. announced that it expects to receive $1.5 million in funding	CI
Feb. 10	Venus Concept Inc.(NasdaqCM:VERO) dropped from S&P TMI Index	CI
Feb. 05	Venus Concept Inc.(OTCPK:VERO) dropped from NASDAQ Composite Index	CI
Jan. 21	Venus Concept announces intention to voluntary delist from Nasdaq and deregister with SEC	RE
Jan. 21	Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC	AQ
Jan. 21	Top Premarket Gainers	MT
Jan. 21	Venus Concept Inc. Announces Voluntary Delisting from NASDAQ and Deregistration with SEC to Enhance Financial Efficiency	CI
Jan. 20	Top Premarket Decliners	MT
Jan. 16	Top Premarket Gainers	MT
Jan. 15	Madryn Asset Management Engages with Venus Concept Inc. on Cost Reduction and Strategic Initiatives Amid Debt Restructuring Efforts	CI
Jan. 07	Venus Concept Inc - On Dec 31, co & its unit enter consent agreement with Madryn Health Partners & others - SEC filing	RE
Nov. 13	Venus Concept Inc., Q3 2025 Earnings Call, Nov 13, 2025
Nov. 13	Venus Concept Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 13	Medical aesthetic device maker Venus Concept's Q3 revenue misses	RE
Nov. 13	Venus Concept: Q3 Earnings Snapshot	AQ
Nov. 13	Venus Concept Announces Third Quarter 2025 Financial Results	AQ
Nov. 10	Venus Concept Gets FDA Clearance to Market Platform for Skin Treatment	MT
Nov. 10	Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments	AQ
Nov. 10	Venus Concept Inc. Receives 510(K) for the Venus NOVA, Its Most Advanced Multi- Application Platform for Non-Invasive Body and Skin Treatments	CI
25-10-02	Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction	AQ
25-10-01	Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025	AQ